市場調査レポート
商品コード
1468143
湿潤創傷被覆材市場:製品、用途、エンドユーザー、地域別、2024~2032年Moist Wound Dressings Market by Product, Application, End User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
湿潤創傷被覆材市場:製品、用途、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
湿潤創傷被覆材の世界市場規模は2023年に50億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに75億米ドルに達し、2024~2032年の間に4.4%の成長率(CAGR)を示すと予測しています。医療専門家、患者、介護者の意識の高まり、償還政策による医療製品や治療法の広範な採用、手術手技の進歩などが市場を推進する主要要因です。
湿潤創傷被覆材は、より迅速で効果的な治癒を促進するために湿潤環境を育成する高度創傷ケアソリューションの一種です。これらの被覆材は創床に水分を保持または供給し、自己溶解性剥離や細胞増殖などの自然治癒プロセスを促進します。アルギン酸塩、ハイドロコロイド、ハイドロゲル、発泡体などの材料で構成され、ゲル、クリーム、フィルムなどさまざまな形態があります。創傷を湿潤状態に保つことで、瘢痕や組織損傷の軽減、疼痛の軽減、創傷の乾燥や治癒を遅らせるかさぶたの形成を防ぐことができます。湿潤創傷被覆材は創傷を感染から守り、滲出液を吸収する働きもあるため、慢性創傷、手術創、熱傷、潰瘍に理想的です。したがって、湿潤創傷被覆材は最適な創傷治癒条件を促進する上で重要な役割を果たしています。
人口増加、平均寿命の伸び、慢性疾患の流行などの要因により、医療支出は増加の一途をたどっています。医療支出の増加に伴い、創傷ケア管理への資源配分が増加しています。さらに、湿潤創傷被覆材の利点に関する医療専門家、患者、介護者の意識が高まっています。医療団体や創傷ケア協会が実施する教育イニシアティブ、トレーニングプログラム、啓発キャンペーンは、湿潤被覆材の利点に関する知識の普及に大きな役割を果たしています。これとは別に、償還政策や保険適用は医療製品や治療法の採用に大きな影響を与えます。湿潤創傷被覆材に対する好意的な償還政策は、医療提供者にこれらの製品の処方と利用を促しています。さらに、手術手技の進歩や低侵襲手術へのシフトは、これらのアプローチに適合する湿潤被覆材の需要に貢献しています。手術件数の増加が湿潤創傷被覆材の市場成長を後押ししています。
慢性創傷の増加
褥瘡、糖尿病性足潰瘍、静脈性下腿潰瘍などの慢性創傷は、世界的に重大な医療課題となっています。これに加え、人口の高齢化、糖尿病の罹患率の上昇、運動能力の低い人の増加が慢性創傷の有病率増加の一因となっています。湿潤創傷被覆材は、最適な治癒環境を作り出すことができるため、慢性創傷を管理するための効果的な治療オプションとして注目されています。これらの被覆材は湿潤環境を維持し、創傷のデブリードメントを促進し、肉芽組織の形成を促進することで創傷治癒プロセスを促進します。慢性創傷を持つ患者層の拡大が、湿潤創傷被覆材の市場需要を牽引すると予想されます。
費用対効果の高い創傷管理への注目の高まり
近年、世界中の医療システムは、質の高いケアを提供しながらもコスト抑制に努めています。その結果、費用対効果の高い創傷管理ソリューションが重視されるようになっています。湿潤創傷被覆材は、ガーゼ被覆材のような従来の創傷ケア方法と比較して費用対効果が高いため、人気を集めています。湿潤被覆材は交換回数が少なく、創傷汚染のリスクを最小限に抑え、追加治療の必要性を減らすため、全体的なコスト削減につながります。さらに、湿潤創傷被覆材は患者の快適性と利便性を向上させ、治療レジメンのコンプライアンス向上につながります。湿潤創傷被覆材に関連する費用対効果と潜在的な節約効果により、医療現場での採用が進むと予想されます。
湿潤創傷被覆材の技術的進歩
湿潤創傷被覆材市場は継続的な技術革新と技術的進歩を遂げています。メーカーは、優れた湿度管理、通気性の向上、滲出液吸収の改善、装着時間の延長を実現する高度な被覆材の開発に注力しています。ハイドロゲル、発泡体、フィルム、アルギン酸塩などの高度な被覆材が湿潤創傷被覆材に組み込まれ、創傷治癒の成果を高めています。さらに、被覆材に抗菌剤を配合することで、創傷感染対策にも役立っています。湿潤創傷被覆材の技術的進歩は、患者の快適性とコンプライアンスを向上させるだけでなく、治癒率の向上にも貢献しています。医療専門家や患者がこうした先進的な製品を知るようになるにつれ、湿潤創傷被覆材の需要が市場に貢献しています。
The global moist wound dressings market size reached US$ 5.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032. The rising awareness among healthcare professionals, patients, and caregivers, the widespread adoption of medical products and treatments due to reimbursement policies, and the advancements in surgical techniques are some of the major factors propelling the market.
Moist wound dressings are a type of advanced wound care solution that fosters a moist environment to facilitate faster, more effective healing. These dressings can retain or donate moisture to the wound bed, encouraging natural healing processes, including autolytic debridement and cell proliferation. They're comprised of materials such as alginates, hydrocolloids, hydrogels, or foams, and they come in various forms including gels, creams, films, and more. By keeping the wound moist, these dressings aid in the reduction of scarring and tissue damage, reduce pain, and prevent the wound from drying out and forming a scab, which can delay healing. Moist wound dressings also assist in protecting the wound from infection and absorbing exudate, making them ideal for chronic wounds, surgical wounds, burns, and ulcers. Therefore, moist wound dressings play a crucial role in promoting optimal wound healing conditions.
Healthcare expenditure continues to rise due to factors such as population growth, increasing life expectancy, and the prevalence of chronic diseases. As healthcare spending increases, there is a greater allocation of resources toward wound care management. In addition, the rising awareness among healthcare professionals, patients, and caregivers regarding the benefits of moist wound dressings. Educational initiatives, training programs, and awareness campaigns conducted by healthcare organizations and wound care associations have played a significant role in disseminating knowledge about the advantages of moist dressings. Apart from this, reimbursement policies and insurance coverage significantly impact the adoption of medical products and treatments. Favorable reimbursement policies for moist wound dressings encourage healthcare providers to prescribe and utilize these products. Furthermore, advancements in surgical techniques and a shift towards minimally invasive procedures contribute to the demand for moist dressings, as they are compatible with these approaches. The increasing volume of surgical procedures drives the market growth for moist wound dressings.
Increasing Prevalence of Chronic Wounds
Chronic wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, have become a significant healthcare challenge worldwide. Along with this, the aging population, rising incidence of diabetes, and a growing number of individuals with limited mobility contribute to the increasing prevalence of chronic wounds. Moist wound dressings have gained prominence as an effective treatment option for managing chronic wounds due to their ability to create an optimal healing environment. These dressings maintain a moist environment, facilitate wound debridement, and enhance the wound healing process by promoting granulation tissue formation. The expanding patient pool with chronic wounds is expected to drive the demand for moist wound dressings in the market.
Growing Emphasis on Cost-effective Wound Management
In recent years, healthcare systems across the globe have been striving to contain costs while delivering quality care. As a result, there is a growing emphasis on cost-effective wound management solutions. Moist wound dressings are gaining popularity due to their cost-effectiveness compared to traditional wound care methods, such as gauze dressings. Moist dressings require fewer changes, minimize the risk of wound contamination, and reduce the need for additional treatments, resulting in overall cost savings. Additionally, moist wound dressings offer improved patient comfort and convenience, leading to better compliance with treatment regimens. The cost-effectiveness and potential savings associated with moist wound dressings are expected to drive their adoption in healthcare settings.
Technological Advancements in Moist Wound Dressings
The market for moist wound dressings is experiencing continuous innovation and technological advancements. Manufacturers are focusing on developing advanced dressings that offer superior moisture management, enhanced breathability, improved exudate absorption, and prolonged wear time. Advanced dressing materials such as hydrogels, foams, films, and alginates are being incorporated into moist wound dressings to provide better wound-healing outcomes. Moreover, the integration of antimicrobial agents into dressings helps combat wound infections. Technological advancements in moist wound dressings not only improve patient comfort and compliance but also contribute to better healing rates. As healthcare professionals and patients become aware of these advanced products, the demand for moist wound dressings is contributing to the market.
IMARC Group provides an analysis of the key trends in each segment of the global moist wound dressings market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.
Foam Dressings
Hydrocolloid Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Collagen Dressings
Others
Foam dressings dominate the market
The report has provided a detailed breakup and analysis of the market based on the product. This includes foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, and others. According to the report, foam dressings represented the largest segment.
Foam dressings have emerged as a popular product in the moist wound dressings industry, and their market growth is driven by several factors. Additionally, foam dressings offer excellent absorption capabilities, effectively managing moderate to heavily exuding wounds. The ability to absorb and lock away excess wound fluid reduces the risk of maceration and promotes a moist wound environment conducive to healing. In addition, foam dressings provide a cushioning effect, protecting the wound from external trauma and minimizing pain. This feature makes them particularly suitable for pressure ulcers, surgical wounds, and other injuries requiring extra protection. Furthermore, foam dressings are highly versatile, easily conforming to wound contours, and can be used on both shallow and deep wounds. Furthermore, advancements in foam dressing technology, such as the incorporation of silver or other antimicrobial agents, further enhance their efficacy in preventing and managing wound infections.
Acute Wounds
Surgical and Traumatic Wounds
Burns
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Others
Chronic wounds hold the largest share in the market
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes acute wounds (surgical and traumatic wounds and burns) and chronic wounds (diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others). According to the report, chronic wounds accounted for the largest market share.
The application of moist wound dressings in the management of chronic wounds is driven by the increasing prevalence of chronic wounds, including pressure ulcers, diabetic foot ulcers, and venous leg ulcers, which is a significant driver. The aging population, rising incidence of diabetes, and lifestyle factors contribute to the growing burden of chronic wounds, necessitating effective treatment options. Moist wound dressings create an optimal healing environment, promoting granulation tissue formation and facilitating the wound healing process. In addition, the technological advancements in moist wound dressings specifically tailored for chronic wounds fuel their market growth. These advancements include dressings with enhanced moisture management, improved exudate absorption, and prolonged wear time, all of which contribute to better healing outcomes. Moreover, the emphasis on cost-effective wound management is a crucial driver for moist wound dressings in chronic wound applications.
Hospitals
Specialty Clinics
Homecare
Others
Hospitals dominate the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, specialty clinics, homecare, and others. According to the report, hospitals represented the largest segment.
The application of moist wound dressings in hospitals is driven by the escalating number of patients with acute and chronic wounds. The rising demand for moist wound dressings in hospitals is due to the need to provide effective wound care and promote optimal healing outcomes. Along with this, hospitals strive to enhance patient comfort and satisfaction while delivering quality care. Moist wound dressings offer advantages such as improved pain management, reduced risk of infection, and enhanced wound healing, which contribute to better patient experiences. Moreover, hospitals focus on infection control and prevention, and moist dressings with antimicrobial properties help address this concern by minimizing the risk of wound infections. Additionally, it helps maintain an ideal moisture balance in the wound bed, which is crucial for promoting healing. It can either retain moisture in dry wounds or absorb excess moisture in heavily exuding wounds, ensuring the right level of moisture for optimal healing.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest moist wound dressings market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The moist wound dressings industry in North America is driven by several market drivers. The region has a high prevalence of chronic diseases such as diabetes, obesity, and cardiovascular conditions, which contribute to the increasing incidence of chronic wounds. Along with this, the growing aging population in North America further fuels the demand for moist wound dressings as this demographic is more prone to chronic wounds. In addition, North America has a well-established healthcare infrastructure with advanced wound care facilities and a strong emphasis on quality patient care. Healthcare providers in the region recognize the benefits of moist wound dressings in promoting faster healing, reducing complications, and improving patient outcomes. Furthermore, technological advancements and innovations in the field of wound care are prevalent in North America.
The global moist wound dressings market is experiencing significant growth due to the development of advanced products to offer better wound care solutions. This includes hydrogels, hydrocolloids, alginates, and foam dressings that promote moist wound healing. Along with this, the escalating number of partnerships and collaborations to enhance research and development efforts, expand geographical reach, or combine resources and expertise to create new products is significantly supporting the market. In addition, companies are providing training and educational resources for healthcare professionals and patients to understand the advantages of moist wound healing, significantly supporting the marketing. With the rise of digital health and telemedicine, some companies are working on integrating their products with digital health platforms to enhance patient monitoring and care.
3M Company
Advanced Medical Solutions Group plc
B. Braun Medical Inc.
Cardinal Health Inc.
Coloplast A/S
Convatec Inc.
Hartmann AG
Hollister Incorporated
Lohmann & Rauscher
Medline Industries Inc.
Molnlycke Health Care AB
Scapa Group Limited
Smith & Nephew Plc
In July 2023, Coloplast A/S agreed to purchase an Icelandic biologic wound care company Kerecis. Kerecis gives a compelling potential for Coloplast to penetrate the fast-growing, US-centric biologics industry, therefore strategically enhancing its footprint in the advanced wound care market.
In May 2023, Smith & Nephew Plc. announced Its PICO single-use negative pressure wound therapy systems have been awarded an innovative technology contract by Vizient, Inc.
In 2022, Hartmann AG has partnered with Rimasys Group to integrate high-quality surgical training with leading operating room (OR) products, specifically targeting orthopedic and emergency care surgeons. This collaboration aims to provide comprehensive support to surgeons by offering state-of-the-art products and innovative surgical education through realistic training simulations, ultimately striving for optimal patient outcomes.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.